Download Supporting Information 4: 435 articles exclusion: 1

Supporting Information 4: 435 articles exclusion:
1.
Alagusundaramoorthy SS, Gedaly R. Role of surgery and transplantation in the treatment of
hepatic metastases from neuroendocrine tumor. World journal of gastroenterology : WJG.
2014;20:14348-14358.
2.
Bhalla A, Sandhu F, Sieber S. Primary adrenal leiomyosarcoma: a case report and review of
the literature. Connecticut medicine. 2014;78:403-407.
3.
Chung H, Chapman WC. Liver transplantation for metastatic neuroendocrine tumors.
Advances in surgery. 2014;48:235-252.
4.
Clark ME, Smith RR. Liver-directed therapies in metastatic colorectal cancer. Journal of
gastrointestinal oncology. 2014;5:374-387.
5.
D'Haese JG, Tosolini C, Ceyhan GO, et al. Update on surgical treatment of pancreatic
neuroendocrine neoplasms. World journal of gastroenterology : WJG. 2014;20:13893-13898.
6.
Hori T, Takaori K, Uemoto S. Pancreatic neuroendocrine tumor accompanied with multiple
liver metastases. World journal of hepatology. 2014;6:596-600.
7.
Kolbeck KJ, Farsad K. Catheter-based treatments for hepatic metastases from neuroendocrine
tumors. AJR. American journal of roentgenology. 2014;203:717-724.
8.
Kopljar M, Patrlj L, Busic Z, et al. Potential use of Doppler perfusion index in detection of
occult liver metastases from colorectal cancer. Hepatobiliary surgery and nutrition.
2014;3:259-267.
9.
Lahat E, Eshkenazy R, Zendel A, et al. Complications after percutaneous ablation of liver
tumors: a systematic review. Hepatobiliary surgery and nutrition. 2014;3:317-323.
10. Magata H, Kondo K, Otani K, et al. [A case of long-term survival after low-dose FP systemic
chemotherapy for a tumor thrombus in the inferior caval vein and multiple lung metastases from
recurrent hepatocellular carcinoma]. Gan to kagaku ryoho. Cancer & chemotherapy.
2014;41:1147-1150.
11. Nigri G, Petrucciani N, Ferla F, La Torre M, Aurello P, Ramacciato G. Neoadjuvant
chemotherapy for resectable colorectal liver metastases: What is the evidence? Results of a
systematic review of comparative studies. The surgeon : journal of the Royal Colleges of Surgeons
of Edinburgh and Ireland. 2014.
12. Park J, Chen YJ, Lu WP, Fong Y. The Evolution of Liver-Directed Treatments for Hepatic
Colorectal Metastases. Oncology (Williston Park, N.Y.). 2014;28.
13. Patrlj L, Kopljar M, Klicek R, et al. The surgical treatment of patients with colorectal cancer
and liver metastases in the setting of the "liver first" approach. Hepatobiliary surgery and nutrition.
2014;3:324-329.
14. Rossi RE, Massironi S, Conte D, Peracchi M. Therapy for metastatic pancreatic
neuroendocrine tumors. Annals of translational medicine. 2014;2:8.
15. Treasure T, Milosevic M, Fiorentino F, Pfannschmidt J. History and present status of
pulmonary metastasectomy in colorectal cancer. World journal of gastroenterology : WJG.
2014;20:14517-14526.
16. Wei IH, Healy MA, Wong SL. Surgical treatment options for stage IV melanoma. The
Surgical clinics of North America. 2014;94:1075-1089, ix.
17. Zendel A, Lahat E, Dreznik Y, Zakai BB, Eshkenazy R, Ariche A. "Vanishing liver
metastases"-A real challenge for liver surgeons. Hepatobiliary surgery and nutrition.
2014;3:295-302.
18. Farmer RG. Preoperative preparation of the patients with carcinoma of the colon. The
Surgical clinics of North America. 1975;55:1335-1341.
19. Goldring J, McNaught W, Scott A, Gillespie G. Prophylactic oral antimicrobial agents in
elective colonic surgery. A controlled trial. Lancet. 1975;2:997-1000.
20. Bruckner R, Kempf P, Kutzner J, Brunner H. [Preliminary results of preoperative
radiotherapy in carcinoma of the rectum (author's transl)]. Deutsche medizinische Wochenschrift
(1946). 1977;102:195-198.
21. Kligerman MM. Radiotherapy and rectal cancer. Cancer. 1977;39:896-900.
22. Taylor I, Brooman P, Rowling JT. Adjuvant liver perfusion in colorectal cancer: initial results
of a clinical trial. British medical journal. 1977;2:1320-1322.
23. Yura J, Kato F, Shibata K. Postoperative infections in colorectal surgery. International surgery.
1978;63:61-62.
24. Keighley MR, Arabi Y, Alexander-Williams J, Youngs D, Burdon DW. Comparison between
systemic and oral antimicrobial prophylaxis in colorectal surgery. Lancet. 1979;1:894-897.
25. Molin K, Rieger A. Effect of preoperative oral administration of oxytetracycline and
neomycin on postoperative infectious complications in cases of cancer coli-recti. Acta chirurgica
Scandinavica. 1979;145:177-183.
26. Taylor I, Rowling J, West C. Adjuvant cytotoxic liver perfusion for colorectal cancer. The
British journal of surgery. 1979;66:833-837.
27. Terranova O, Sandei F, Rebuffat C, Maruotti R, Pezzuoli G. Management of the perineal
wound after rectal excision for neoplastic disease: a controlled clinical trial. Diseases of the colon
and rectum. 1979;22:228-233.
28. Bolton RA, Britton DC. Restorative surgery of the rectum with a circumferential stapler.
Lancet. 1980;1:850-851.
29. Nilsson E, Lamke LO, Liljedahl SO, Elfstrom K. Is albumin therapy worthwhile in surgery
for colorectal cancer? Acta chirurgica Scandinavica. 1980;146:619-622.
30. Aeberhard P, Fluckiger M, Berger J, Novak A. [Parenteral antibiotic prophylaxis or oral
antimicrobial bowel preparation for colorectal surgery (author's transl)]. Langenbecks Archiv fur
Chirurgie. 1981;353:233-240.
31. Oberst MT, Graham D, Geller NL, Stearns MW, Jr., Tiernan E. Catheter management
programs and postoperative urinary dysfunction. Research in nursing & health. 1981;4:175-181.
32. Balslev I, Pedersen M, Teglbjaerg PS, et al. Postoperative radiotherapy in rectosigmoid
cancer Dukes' B and C: interim report from a randomized multicentre study. British journal of
cancer. 1982;46:551-556.
33. Finlay IG, Meek DR, Gray HW, Duncan JG, McArdle CS. Incidence and detection of occult
hepatic metastases in colorectal carcinoma. British medical journal (Clinical research ed.).
1982;284:803-805.
34. Steele G, Jr., Ellenberg S, Ramming K, et al. CEA monitoring among patients in
multi-institutional adjuvant G.I. therapy protocols. Annals of surgery. 1982;196:162-169.
35. Graffner H, Fredlund P, Olsson SA, Oscarson J, Petersson BG. Protective colostomy in low
anterior resection of the rectum using the EEA stapling instrument. A randomized study. Diseases
of the colon and rectum. 1983;26:87-90.
36. Knysh VI, Aliev BM, Barsukov Iu A. [Combination treatment of rectal cancer using 2
variants of preoperative concentration gamma therapy]. Meditsinskaia radiologiia. 1983;28:12-17.
37. Roth E, Funovics J, Karner J, Huk I, Schulz F, Fritsch A. [Lack of stimulation of nitrogen
retention and plasma protein synthesis due to increased intake of branched-chain amino acids].
Infusionstherapie und klinische Ernahrung. 1983;10:259-266.
38. Bauer E, Graber R, Brodtke R, Lunstedt B, Seifert J. [Nutrition physiologic, immunologic
and clinical parameters in prospective randomized patients by enteral or parenteral nutrition
therapy following large intestine operations]. Infusionstherapie und klinische Ernahrung.
1984;11:165-167.
39. Boulis-Wassif S, Gerard A, Loygue J, Camelot D, Buyse M, Duez N. Final results of a
randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in
combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization
on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer.
1984;53:1811-1818.
40. Cummings BJ. Adjuvant radiation therapy for rectal adenocarcinoma. Diseases of the colon
and rectum. 1984;27:826-836.
41. Higgins GA, Donaldson RC, Rogers LS, Juler GL, Keehn RJ. Efficacy of MER
immunotherapy when added to a regimen of 5-fluorouracil and methyl-CCNU following resection
for carcinoma of the large bowel. A Veterans Administration Surgical Oncology Group report.
Cancer. 1984;54:193-198.
42. Knysh VI, Aliev BM, Bondar GV, Dvoirin VV, Barsukov Iu A. [Effectiveness of combined
and complex treatment of patients with operable cancer of the rectum]. Voprosy onkologii.
1984;30:42-48.
43. Kujath P, Bruch HP, Schmidt E, Doll W. [Perioperative prophylaxis in elective colorectal
surgery]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 1984;55:519-522.
44. Lohr J, Wagner PK, Rothmund M. [Perioperative antibiotic prophylaxis (single or multiple
dose) in elective colorectal surgery. A randomized study]. Der Chirurg; Zeitschrift fur alle Gebiete
der operativen Medizen. 1984;55:512-514.
45. Taylor RH, Gilbert JM, Evans MG, Lane HG, Cassell PG. Prospective serial liver ultrasound
scanning in resectable colorectal cancer treated with adjuvant razoxane. Clinical & experimental
metastasis. 1984;2:321-331.
46. Wacha H, Probst M. [Healing of the sacral wound cavity after abdomino-perineal extirpation
of the rectum. A prospective randomized study using metronidazole]. Der Chirurg; Zeitschrift fur
alle Gebiete der operativen Medizen. 1984;55:29-31.
47. Athanasiadis S, Kuhlgatz C, Hahnel E. [Perioperative antibiotic prevention in colon and
rectum surgery. A randomized study on the value of single dose prevention]. Zentralblatt fur
Chirurgie. 1985;110:532-538.
48. Cedermark B, Theve NO, Rieger A, et al. Preoperative short-term radiotherapy in rectal
carcinoma. A preliminary report of a prospective randomized study. Cancer. 1985;55:1182-1185.
49. Duus BR, Philipsen T, Christensen JD, Lundvall F, Sondergaard J. Refractory condylomata
acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment.
Genitourinary medicine. 1985;61:59-61.
50. Fleites RA, Marshall JB, Eckhauser ML, Mansour EG, Imbembo AL, McCullough AJ. The
efficacy of polyethylene glycol-electrolyte lavage solution versus traditional mechanical bowel
preparation for elective colonic surgery: a randomized, prospective, blinded clinical trial. Surgery.
1985;98:708-717.
51. Jacobsen MB, Sorensen B, Melsom M, Aspestrand F, Andersen J. [Postoperative control of
patients operated on for colonic cancer. A comparative study of coloscopy and double contrast
radiography]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
1985;105:742-743.
52. Pahlman L, Glimelius B, Graffman S. Pre- versus postoperative radiotherapy in rectal
carcinoma: an interim report from a randomized multicentre trial. The British journal of surgery.
1985;72:961-966.
53. Parker MC, Ashby EC, Nicholls MW, Dowding CH, Brookes JC. Povidone-iodine bowel
irrigation before resection of colorectal carcinoma. Annals of the Royal College of Surgeons of
England. 1985;67:227-228.
54. Winkler R. [Adjuvant radiotherapy in rectosigmoid cancers]. Zentralblatt fur Chirurgie.
1985;110:124-136.
55. Balslev I, Pedersen M, Teglbjaerg PS, et al. Postoperative radiotherapy in Dukes' B and C
carcinoma of the rectum and rectosigmoid. A randomized multicenter study. Cancer.
1986;58:22-28.
56. Fujimoto M, Sakai K, Ueda T. [Significance of amikacin administered orally prior to
operation for prevention of postoperative infections in colonic cancer surgery]. The Japanese
journal of antibiotics. 1986;39:2889-2896.
57. Higgins GA, Humphrey EW, Dwight RW, Roswit B, Lee LE, Jr., Keehn RJ. Preoperative
radiation and surgery for cancer of the rectum. Veterans Administration Surgical Oncology Group
Trial II. Cancer. 1986;58:352-359.
58. Kingston RD, Duthie J. Serious postoperative bleeding associated with a single intravenous
dose of cefuroxime and metronidazole. The Journal of hospital infection. 1986;7:100-101.
59. Nakazato H, Ichihashi H, Kondo T. [Clinical results of a randomized controlled trial on the
effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively
resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai
Gastrointestinal Oncology Group]. Gan to kagaku ryoho. Cancer & chemotherapy.
1986;13:308-318.
60. Short-term preoperative radiotherapy for adenocarcinoma of the rectum. An interim analysis
of a randomized multicenter trial. Stockholm Rectal Cancer Study Group. American journal of
clinical oncology. 1987;10:369-375.
61. Abdel-Nabi HH, Schwartz AN, Higano CS, Wechter DG, Unger MW. Colorectal carcinoma:
detection with indium-111 anticarcinoembryonic-antigen monoclonal antibody ZCE-025.
Radiology. 1987;164:617-621.
62. Adalsteinsson B, Pahlman L, Hemmingsson A, Glimelius B, Graffman S. Computed
tomography in early diagnosis of local recurrence of rectal carcinoma. Acta radiologica
(Stockholm, Sweden : 1987). 1987;28:41-47.
63. Fasth S, Hulten L, Magnusson O, Nordgren S, Warnold I. The immediate and long-term
effects of postoperative total parenteral nutrition on body composition. International journal of
colorectal disease. 1987;2:139-145.
64. Fasth S, Hulten L, Magnusson O, Nordgren S, Warnold I. Postoperative complications in
colorectal surgery in relation to preoperative clinical and nutritional state and postoperative
nutritional treatment. International journal of colorectal disease. 1987;2:87-92.
65. Hallerback B, Carlsen E, Carlsson K, et al. Beta-adrenoceptor blockade in the treatment of
postoperative adynamic ileus. Scandinavian journal of gastroenterology. 1987;22:149-155.
66. Racette DL, Chang FC, Trekell ME, Farha GJ. Is nasogastric intubation necessary in colon
operations? American journal of surgery. 1987;154:640-642.
67. Windle R, Bell PR, Shaw D. Five year results of a randomized trial of adjuvant 5-fluorouracil
and levamisole in colorectal cancer. The British journal of surgery. 1987;74:569-572.
68. Zilli L, Pietroiusti M, Bertario L. Colonoscopy in ostomy patients. Results at the first
postoperative examination. Diseases of the colon and rectum. 1987;30:687-691.
69. Balslev I, Pedersen M, Teglbjaerg PS, et al. [Postoperative radiotherapy in cancer of the
rectum and rectosigmoid. A prospective randomized multicenter study]. Ugeskrift for laeger.
1988;150:1958-1961.
70. Buess G, Kipfmuller K, Ibald R, et al. Clinical results of transanal endoscopic microsurgery.
Surgical endoscopy. 1988;2:245-250.
71. Chlebowski RT, Nystrom S, Reynolds R, Weiner JM, Bateman JR. Long-term survival
following levamisole or placebo adjuvant treatment of colorectal cancer: a Western Cancer Study
Group Trial. Oncology. 1988;45:141-143.
72. Coppa GF, Eng K. Factors involved in antibiotic selection in elective colon and rectal surgery.
Surgery. 1988;104:853-858.
73. Grundmann R, Weber F, Kluger J, Wienand P, Pulverer G. [Preoperative nonspecific
immunostimulation with Propionibacterium granulosum KP-45 in patients with colorectal cancer.
A prospective randomized study]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
1988;59:272-278.
74. Kikuchi K, Shimizu H. [Clinical study of postoperative infection of gastrointestinal cancer.
Randomized study of preventive efficacy of cefmetazole versus cephalothin in postoperative
infection
of
gastric
and
colorectal
cancer].
The
Japanese
journal
of
antibiotics.
1988;41:1480-1492.
75. Lau WY, Chu KW, Poon GP, Ho KK. Prophylactic antibiotics in elective colorectal surgery.
The British journal of surgery. 1988;75:782-785.
76. Petrelli NJ, Conte CC, Herrera L, Stulc J, O'Neill P. A prospective, randomized trial of
perioperative prophylactic cefamandole in elective colorectal surgery for malignancy. Diseases of
the colon and rectum. 1988;31:427-429.
77. Vara-Thorbeck R, Rosell J, Salvi M, Vara-Thorbeck C. [Preoperative hemodilution for the
prevention of postoperative deep venous thrombosis and early infectious complications in
colorectal resections]. Zentralblatt fur Chirurgie. 1988;113:1204-1209.
78. Wiggers T, Jeekel J, Arends JW, et al. No-touch isolation technique in colon cancer: a
controlled prospective trial. The British journal of surgery. 1988;75:409-415.
79. Bittner R, Butters M, Rampf W, Kapfer X. [Duration of the preventive use of antibiotics in
colorectal surgery--single administration versus short-term prevention]. Langenbecks Archiv fur
Chirurgie. 1989;374:272-279.
80. Fielding LP, Phillips RK, Hittinger R. Factors influencing mortality after curative resection
for large bowel cancer in elderly patients. Lancet. 1989;1:595-597.
81. Jauch KW, Gunther B, Wicklmayr M, Dietze GJ, Schrofel L. Bradykinin infusion in long
term postoperative parenteral nutrition improves nitrogen balance and protein synthesis. Advances
in experimental medicine and biology. 1989;247A:581-585.
82. Mertes N, Pfisterer M, Winde G, et al. [Protein oriented peripheral venous nutrition following
surgical trauma]. Infusionstherapie (Basel, Switzerland). 1989;16:60-66.
83. Mitomi T, Tsuchiya S, Iijima N, et al. [Randomized controlled study on adjuvant
immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study
Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum]. Gan to
kagaku ryoho. Cancer & chemotherapy. 1989;16:2241-2249.
84. Stehle P, Zander J, Mertes N, et al. Effect of parenteral glutamine peptide supplements on
muscle glutamine loss and nitrogen balance after major surgery. Lancet. 1989;1:231-233.
85. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective
randomized trial. Stockholm Rectal Cancer Study Group. Cancer. 1990;66:49-55.
86. Alberts DS, Einspahr J, Rees-McGee S, et al. Effects of dietary wheat bran fiber on rectal
epithelial cell proliferation in patients with resection for colorectal cancers. Journal of the National
Cancer Institute. 1990;82:1280-1285.
87. Beart RW, Jr., Moertel CG, Wieand HS, et al. Adjuvant therapy for resectable colorectal
carcinoma with fluorouracil administered by portal vein infusion. A study of the Mayo Clinic and
the North Central Cancer Treatment Group. Archives of surgery (Chicago, Ill. : 1960).
1990;125:897-901.
88. Braga M, Baccari P, Di Palo S, et al. Effectiveness of perioperative short-term antibiotic
prophylaxis in reducing surgical risk induced by malnutrition and anergy. Acta chirurgica
Scandinavica. 1990;156:751-757.
89. Burke ER, Welvaart K. Complications of stapled anastomoses in anterior resection for rectal
carcinoma: colorectal anastomosis versus coloanal anastomosis. Journal of surgical oncology.
1990;45:180-183.
90. Butters M, Miller W, Bittner R. [Effect of enteral and parenteral nutrition on glucose
tolerance
in
the
early
postoperative
phase].
Infusionstherapie
(Basel,
Switzerland).
1990;17:257-260.
91. Harju E, Huttunen J, Yla-Herttuala S. Clinical and metabolic effects and wound healing
metabolism in controlled total parenteral nutrition with high vs. low nitrogen content for seven
days after abdominoperineal rectum resection for carcinoma. Chirurgia italiana. 1990;42:151-164.
92. Horn A, Morild I, Dahl O. Tumour shrinkage and down staging after preoperative radiation
of rectal adenocarcinomas. Radiotherapy and oncology : journal of the European Society for
Therapeutic Radiology and Oncology. 1990;18:19-28.
93. Knysh VI, Bondar GV, Barsukov Iu A, Timofeev Iu M, Basheev V. [Combined treatment of
rectal cancer using intensive macrofractional preoperative irradiation]. Khirurgiia. 1990:53-57.
94. Lehner B, Schlag P, Liebrich W, Schirrmacher V. Postoperative active specific immunization
in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell
vaccine. Cancer immunology, immunotherapy : CII. 1990;32:173-178.
95. Loser C, Folsch UR, Paprotny C, Creutzfeldt W. Polyamines in human gastrointestinal
malignancies. Digestion. 1990;46 Suppl 2:430-438.
96. Moertel CG, Fleming TR, Macdonald JS, et al. Levamisole and fluorouracil for adjuvant
therapy of resected colon carcinoma. The New England journal of medicine. 1990;322:352-358.
97. Nikolov K. [The postoperative changes in the cellular immune response in vivo in patients
with colorectal carcinoma after preoperative acute normovolemic hemodilution--a randomized,
prospective and comparative study]. Khirurgiia. 1990;43:25-30.
98. Nikolov K, Videlov D, Lazarov S, Kalcheva V, Atanasov A. [A modified technic of
preoperative acute normovolemic hemodilution--the advantages and economic effect of its use in
planned colorectal surgery]. Khirurgiia. 1990;43:30-37.
99. Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid
carcinoma. Report from a randomized multicenter trial. Annals of surgery. 1990;211:187-195.
100. Peters KM, Bornhofen B, Grundmann R, et al. [Neopterin as a marker of aspecific
immunostimulation with Propionibacterium avidum KP-40 in patients with gastrointestinal tumors.
A prospective randomized study]. Medizinische Klinik (Munich, Germany : 1983).
1990;85:421-424.
101. Rosenthal SA, Trock BJ, Coia LR. Randomized trials of adjuvant radiation therapy for rectal
carcinoma: a review. Diseases of the colon and rectum. 1990;33:335-343.
102. Rouffet F, Mathon C, Vendroux J. [Extend of colonic excision in the curative treatment of
cancers of the left colon. Left or segmental hemicolectomy? A controlled prospective multicenter
study]. Chirurgie; memoires de l'Academie de chirurgie. 1990;116:419-423; discussion 424.
103. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma:
impact of surgical resection on the natural history. The British journal of surgery.
1990;77:1241-1246.
104. Schlag P, Hohenberger P, Herfarth C. Resection of liver metastases in colorectal
cancer--competitive analysis of treatment results in synchronous versus metachronous metastases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology
and the British Association of Surgical Oncology. 1990;16:360-365.
105. Thirlby RC. Preoperative radiotherapy is better than postoperative radiotherapy in patients
with rectal cancer. Gastroenterology. 1990;99:895-897.
106. Wereldsma JC, Bruggink ED, Meijer WS, Roukema JA, van Putten WL. Adjuvant portal
liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control.
Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I). Cancer.
1990;65:425-432.
107. Becker JM, Alexander DP. Colectomy, mucosal proctectomy, and ileal pouch-anal
anastomosis. A prospective trial of optimal antibiotic management. Annals of surgery.
1991;213:242-247.
108. Carli F, Webster J, Pearson M, et al. Postoperative protein metabolism: effect of nursing
elderly patients for 24 h after abdominal surgery in a thermoneutral environment. British journal
of anaesthesia. 1991;66:292-299.
109. Daly L. The first international urokinase/warfarin trial in colorectal cancer. Clinical &
experimental metastasis. 1991;9:3-11.
110. Herbert SH, Curran WJ, Jr., Solin LJ, Stafford PM, Lanciano RM, Hanks GE. Decreasing
gastrointestinal morbidity with the use of small bowel contrast during treatment planning for
pelvic irradiation. International journal of radiation oncology, biology, physics. 1991;20:835-842.
111. James RD, Haboubi N, Schofield PF, Mellor M, Salhab N. Prognostic factors in colorectal
carcinoma treated by preoperative radiotherapy and immediate surgery. Diseases of the colon and
rectum. 1991;34:546-551.
112. Marks G, Mohiuddin M, Eitan A, Masoni L, Rakinic J. High-dose preoperative radiation and
radical sphincter-preserving surgery for rectal cancer. Archives of surgery (Chicago, Ill. : 1960).
1991;126:1534-1540.
113. Mutch RS, Hutson PR. Levamisole in the adjuvant treatment of colon cancer. Clinical
pharmacy. 1991;10:95-109.
114. Rosen HR, Marczell AP, Czerwenka E, Stierer MO, Spoula H, Wasl H. Local gentamicin
application for perineal wound healing following abdominoperineal rectum excision. American
journal of surgery. 1991;162:438-441.
115. Steele G, Jr., Bleday R, Mayer RJ, Lindblad A, Petrelli N, Weaver D. A prospective
evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal
Tumor Study Group Protocol 6584. Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 1991;9:1105-1112.
116. Treurniet-Donker AD, van Putten WL, Wereldsma JC, et al. Postoperative radiation therapy
for rectal cancer. An interim analysis of a prospective, randomized multicenter trial in The
Netherlands. Cancer. 1991;67:2042-2048.
117. Yamaguchi A, Ishida T, Nishimura G, et al. Detection by CT during arterial portography of
colorectal cancer metastases to liver. Diseases of the colon and rectum. 1991;34:37-40.
118. Radiation therapy and fluorouracil with or without semustine for the treatment of patients
with surgical adjuvant adenocarcinoma of the rectum. Gastrointestinal Tumor Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1992;10:549-557.
119. Arnaud JP, Bellissant E, Boissel P, et al. Single-dose amoxycillin-clavulanic acid vs.
cefotetan for prophylaxis in elective colorectal surgery: a multicentre, prospective, randomized
study. The PRODIGE Group. The Journal of hospital infection. 1992;22 Suppl A:23-32.
120. Bentzen SM, Balslev I, Pedersen M, et al. Time to loco-regional recurrence after resection of
Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A
multivariate regression analysis. British journal of cancer. 1992;65:102-107.
121. Braga M, Di Francesco A, Gianotti L, Baccari P, Di Carlo V. [Perioperative administration of
thymopentin for the prevention of infections in oncologic surgery]. Minerva chirurgica.
1992;47:125-130.
122. Brivio F, Lissoni P, Tisi E, et al. Effects of a preoperative therapy with interleukin-2 on
surgery-induced lymphocytopenia in cancer patients. Oncology. 1992;49:215-218.
123. Buess G, Mentges B, Manncke K, Starlinger M, Becker HD. Technique and results of
transanal endoscopic microsurgery in early rectal cancer. American journal of surgery.
1992;163:63-69; discussion 69-70.
124. Cafiero F, Gipponi M, Bonalumi U, Piccardo A, Sguotti C, Corbetta G. Prophylaxis of
infection with intravenous immunoglobulins plus antibiotic for patients at risk for sepsis
undergoing surgery for colorectal cancer: results of a randomized, multicenter clinical trial.
Surgery. 1992;112:24-31.
125. Cohen Z, McLeod RS, Stephen W, Stern HS, O'Connor B, Reznick R. Continuing evolution
of the pelvic pouch procedure. Annals of surgery. 1992;216:506-511; discussion 511-502.
126. Coucke PA. Postoperative radiation therapy for rectal cancer: an interim analysis of a
prospective, randomized multicenter trial in The Netherlands. Cancer. 1992;69:3016-3017.
127. Folli S, Wagnieres G, Pelegrin A, et al. Immunophotodiagnosis of colon carcinomas in
patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen.
Proceedings of the National Academy of Sciences of the United States of America.
1992;89:7973-7977.
128. Hermanek P. [Multivisceral resection of colorectal cancer--experiences of the Colorectal
Cancer Study Group]. Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche
Gesellschaft fur Chirurgie. Kongress. 1992:95-100.
129. Hofstad B, Vatn M, Hoff G, Larsen S, Osnes M. Growth of colorectal polyps: design of a
prospective, randomized, placebo-controlled intervention study in patients with colorectal polyps.
European journal of cancer prevention : the official journal of the European Cancer Prevention
Organisation (ECP). 1992;1:415-422.
130. Hoynck van Papendrecht MA, Hop W, Langenhorst BL, Kothe FC, Marquet RL, Jeekel J.
Feasibility of a predeposit autologous blood donation program in colorectal cancer patients: results
from a randomized clinical study. Vox sanguinis. 1992;62:102-107.
131. Kuroda M, Inamura K, Tahara S, et al. Report of a study using phantom materials, and
clinical experience with simultaneous radio-hyperthermotherapy. Acta medica Okayama.
1992;46:417-426.
132. Liu T, Liu Y, He S, Zhang Z, Kligerman MM. Use of radiation with or without WR-2721 in
advanced rectal cancer. Cancer. 1992;69:2820-2825.
133. Lohde E, Scholz L, Gemperle A, et al. [Comparative analysis of mezlocillin/metronidazole
and amoxicillin/clavulanic acid as "one shot" preventive antibiotic administration in colorectal
interventions]. Zentralblatt fur Chirurgie. 1992;117:325-330.
134. Lumley JW, Siu SK, Pillay SP, et al. Single dose ceftriaxone as prophylaxis for sepsis in
colorectal surgery. The Australian and New Zealand journal of surgery. 1992;62:292-296.
135. Mendenhall WM, Bland KI, Copeland EM, 3rd, et al. Does preoperative radiation therapy
enhance the probability of local control and survival in high-risk distal rectal cancer? Annals of
surgery. 1992;215:696-705; discussion 705-696.
136. Mitomi T, Tsuchiya S, Iijima N, et al. Randomized, controlled study on adjuvant
immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study
Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).
Diseases of the colon and rectum. 1992;35:123-130.
137. Nichols PH, Ramsden CW, Ward U, Sedman PC, Primrose JN. Perioperative immunotherapy
with recombinant interleukin 2 in patients undergoing surgery for colorectal cancer. Cancer
research. 1992;52:5765-5769.
138. Poortmans PM, Hamers HP. Postoperative radiation therapy for rectal cancer: an interim
analysis of a prospective, randomized multicenter trial in The Netherlands. Cancer.
1992;69:3017-3019.
139. Riwar A, Schar B, Grotzinger U. [Effect of continuous postoperative analgesia with peridural
bupivacaine on intestinal motility following colorectal resection]. Helvetica chirurgica acta.
1992;58:729-733.
140. Rosenthal SA, Yeung RS, Weese JL, et al. Conservative management of extensive low-lying
rectal carcinomas with transanal local excision and combined preoperative and postoperative
radiation therapy. A report of a phase I-II trial. Cancer. 1992;69:335-341.
141. Shoji Y, Kusunoki M, Fujita S, Yamamura T, Utsunomiya J. Functional role of the preserved
rectal cuff in ileoanal anastomosis. Surgery. 1992;111:266-273.
142. van Ooijen B, Wiggers T, Meijer S, et al. Hepatic resections for colorectal metastases in The
Netherlands. A multiinstitutional 10-year study. Cancer. 1992;70:28-34.
143. Wolters U, Keller HW, Schlesinger A, Pichlmaier H. [Preoperative intestinal lavage with a
polyethyleneglycol-containing solution. A prospective randomized study in comparison with
Ringer's lactate solution]. Zentralblatt fur Chirurgie. 1992;117:412-416.
144. Initial report from a Swedish multicentre study examining the role of preoperative irradiation
in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial. The
British journal of surgery. 1993;80:1333-1336.
145. Bonzanini C, Ubiali P, Invernizzi R. [The use of piperacillin in the preoperative prophylaxis
of colorectal surgery]. Minerva chirurgica. 1993;48:1437-1443.
146. Brivio F, Lissoni P, Barni S, et al. Effects of a preoperative course of interleukin-2 on surgical
and immunobiological variables in patients with colorectal cancer: a phase 2 study. The European
journal of surgery = Acta chirurgica. 1993;159:43-47.
147. Cosimelli M, Tedesco M, Giannarelli D, et al. The role of the administration time of
prophylactic antibiotic therapy in colorectal cancer surgery: a review of 6,069 patients from 36
randomized clinical trials. Annali italiani di chirurgia. 1993;64:527-532.
148. Coucke PA, Cuttat JF, Mirimanoff RO. Adjuvant postoperative accelerated hyperfractionated
radiotherapy in rectal cancer: a feasibility study. International journal of radiation oncology,
biology, physics. 1993;27:885-889.
149. Falk PM, Beart RW, Jr., Wexner SD, et al. Laparoscopic colectomy: a critical appraisal.
Diseases of the colon and rectum. 1993;36:28-34.
150. Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in
adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of
late secondary effects. Diseases of the colon and rectum. 1993;36:564-572.
151. Heiss MM, Mempel W, Delanoff C, Mempel M, Jauch KW, Schildberg FW. [Clinical effects
of blood transfusion-associated immune modulation on outcome of tumor surgery].
Infusionstherapie und Transfusionsmedizin. 1993;20 Suppl 2:25-29.
152. Heiss MM, Mempel W, Jauch KW, et al. Beneficial effect of autologous blood transfusion on
infectious complications after colorectal cancer surgery. Lancet. 1993;342:1328-1333.
153. Huber PJ, Jr., Reiss G. Rectal tumors: treatment with a posterior approach. American journal
of surgery. 1993;166:760-763.
154. Minsky BD, Cohen AM, Kemeny N, et al. The efficacy of preoperative 5-fluorouracil,
high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer. Cancer.
1993;71:3486-3492.
155. Murakami K, Watanabe T, Tadokoro M, et al. [Radioimmunodetection of colorectal cancer,
using anti-CEA monoclonal antibody CEA102: experience of 20 cases]. Nihon Geka Gakkai
zasshi. 1993;94:119-127.
156. Petrelli NJ, Stulc JP, Rodriguez-Bigas M, Blumenson L. Nasogastric decompression
following elective colorectal surgery: a prospective randomized study. The American surgeon.
1993;59:632-635.
157. Quattlebaum JK, Jr., Flanders HD, Usher CH, 3rd. Laparoscopically assisted colectomy.
Surgical laparoscopy & endoscopy. 1993;3:81-87.
158. Sagar PM, Couse N, Kerin M, May J, MacFie J. Randomized trial of drainage of colorectal
anastomosis. The British journal of surgery. 1993;80:769-771.
159. Schirrmacher V, Schlag P, Liebrich W, Patel BT, Stoeck M. Specific immunotherapy of
colorectal carcinoma with Newcastle-disease virus-modified autologous tumor cells prepared from
resected liver metastasis. Annals of the New York Academy of Sciences. 1993;690:364-366.
160. Takahashi T, Horie H, Kojima O, Itoh M. Preoperative combined treatment with radiation,
intraluminal hyperthermia, and 5-fluorouracil suppositories for patients with rectal cancer. Surgery
today. 1993;23:1043-1048.
161. Tate JJ, Kwok S, Dawson JW, Lau WY, Li AK. Prospective comparison of laparoscopic and
conventional anterior resection. The British journal of surgery. 1993;80:1396-1398.
162. Wolmark N, Rockette H, Fisher B, et al. The benefit of leucovorin-modulated fluorouracil as
postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant
Breast and Bowel Project protocol C-03. Journal of clinical oncology : official journal of the
American Society of Clinical Oncology. 1993;11:1879-1887.
163. Adams WJ, Morris DL, Ross WB, Lubowski DZ, King DW, Peters L. Cimetidine preserves
non-specific immune function after colonic resection for cancer. The Australian and New Zealand
journal of surgery. 1994;64:847-852.
164. AhChong K, Yip AW, Lee FC, Chiu KM. Comparison of prophylactic ampicillin/sulbactam
with gentamicin and metronidazole in elective colorectal surgery: a randomized clinical study. The
Journal of hospital infection. 1994;27:149-154.
165. Allardice JT, Abulafi AM, Grahn MF, Williams NS. Adjuvant intraoperative photodynamic
therapy for colorectal carcinoma: a clinical study. Surgical oncology. 1994;3:1-10.
166. Braga M, Costantini E, Di Francesco A, Gianotti L, Baccari P, Di Carlo V. Impact of
thymopentin on the incidence and severity of postoperative infection: a randomized controlled
trial. The British journal of surgery. 1994;81:205-208.
167. Briusov PG, Inoiatov IM, Perekhodov SN. [Prevention of incompetence of sigmoid-rectal
anastomosis after frontal resection of rectum in the treatment of cancer]. Khirurgiia. 1994:29-32.
168. Chlebowski RT, Lillington L, Nystrom JS, Sayre J. Late mortality and levamisole adjuvant
therapy in colorectal cancer. British journal of cancer. 1994;69:1094-1097.
169. Costantino GN, Mukalian GG. Laparoscopic reversal of Hartmann procedure. Journal of
laparoendoscopic surgery. 1994;4:429-433.
170. Delalande JP, Hay JM, Fingerhut A, Kohlmann G, Paquet JC. Perineal wound management
after abdominoperineal rectal excision for carcinoma with unsatisfactory hemostasis or gross
septic contamination: primary closure vs. packing. A multicenter, controlled trial. French
Association for Surgical Research. Diseases of the colon and rectum. 1994;37:890-896.
171. Diez M, Cerdan FJ, Pollan M, et al. Prognostic significance of preoperative serum CA 19.9
assay in patients with colorectal carcinoma. Anticancer research. 1994;14:2819-2825.
172. Eckardt VF, Stamm H, Kanzler G, Bernhard G. Improved survival after colorectal cancer in
patients complying with a postoperative endoscopic surveillance program. Endoscopy.
1994;26:523-527.
173. Elia P, Lombardo G, Delpiano C, Granello M. [Prevention of immunodeficiency and
postoperative infective complications in patients undergoing surgical resection for carcinoma of
the colon-rectum. Clinical study on 50 cases, using thymus hormones and thymopentin in
particular]. Minerva chirurgica. 1994;49:575-580.
174. Elizarova AL, Madzhuga AV, Somonova OV, Larionova VB, Gorobets ES, Anan'ev VS.
[Prevention of hemostatic disorders at different stages of surgical treatment in patients with
colonic cancer]. Anesteziologiia i reanimatologiia. 1994:39-42.
175. Goeters C, Mertes N, Kuhmann M, Lange V, Dietl KH, Lawin P. [Safety and tolerance of a
new dipeptide-containing amino acid solution DP-Gln 20 versus a conventional amino acid
solution Vamin 18EF in patients after elective colon surgery]. Anasthesiologie, Intensivmedizin,
Notfallmedizin, Schmerztherapie : AINS. 1994;29:146-149.
176. Heiss MM, Mempel W, Delanoff C, et al. Blood transfusion-modulated tumor recurrence:
first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal
cancer surgery. Journal of clinical oncology : official journal of the American Society of Clinical
Oncology. 1994;12:1859-1867.
177. Hermanek P, Jr., Wiebelt H, Riedl S, Staimmer D, Hermanek P. [Long-term results of surgical
therapy of colon cancer. Results of the Colorectal Cancer Study Group]. Der Chirurg; Zeitschrift
fur alle Gebiete der operativen Medizen. 1994;65:287-297.
178. Houbiers JG, Brand A, van de Watering LM, et al. Randomised controlled trial comparing
transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.
Lancet. 1994;344:573-578.
179. Houry S, Amenabar J, Rezvani A, Huguier M. Should patients over 80 years old be operated
on for colorectal or gastric cancer? Hepato-gastroenterology. 1994;41:521-525.
180. Kawashima A, Goldman SM, Fishman EK, et al. CT of intraabdominal desmoid tumors: is
the tumor different in patients with Gardner's disease? AJR. American journal of roentgenology.
1994;162:339-342.
181. Leen E, Angerson WJ, Wotherspoon H, Moule B, Cooke TG, McArdle CS. Comparison of
the Doppler perfusion index and intraoperative ultrasonography in diagnosing colorectal liver
metastases. Evaluation with postoperative follow-up results. Annals of surgery. 1994;220:663-667.
182. Letschert JG, Lebesque JV, Aleman BM, et al. The volume effect in radiation-related late
small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative
Group in patients treated for rectal carcinoma. Radiotherapy and oncology : journal of the
European Society for Therapeutic Radiology and Oncology. 1994;32:116-123.
183. Mentges B, Buess G, Raestrup H, Manncke K, Becker HD. TEM results of the Tuebingen
group. Endoscopic surgery and allied technologies. 1994;2:247-250.
184. Minsky BD, Enker WE, Cohen AM, Lauwers G. Local excision and postoperative radiation
therapy for rectal cancer. American journal of clinical oncology. 1994;17:411-416.
185. Mobarhan S, Shiau A, Grande A, et al. beta-Carotene supplementation results in an increased
serum and colonic mucosal concentration of beta-carotene and a decrease in alpha-tocopherol
concentration in patients with colonic neoplasia. Cancer epidemiology, biomarkers & prevention :
a publication of the American Association for Cancer Research, cosponsored by the American
Society of Preventive Oncology. 1994;3:501-505.
186. Nordlinger B, Vaillant JC, Guiguet M, et al. Survival benefit of repeat liver resections for
recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 1994;12:1491-1496.
187. Odariuk TS, Kapuller LL, Podmarenkova LF, Tsar'kov PV, Frolov SA. [Long-term results of
formation of smooth muscle sphincter in the perineal colostomy area in patients after rectal
extirpation]. Khirurgiia. 1994:23-26.
188. O'Riordain MG, Fearon KC, Ross JA, et al. Glutamine-supplemented total parenteral
nutrition enhances T-lymphocyte response in surgical patients undergoing colorectal resection.
Annals of surgery. 1994;220:212-221.
189. Pedersen IK, Burcharth F, Roikjaer O, Baden H. Resection of liver metastases from
colorectal cancer. Indications and results. Diseases of the colon and rectum. 1994;37:1078-1082.
190. Riethmuller G, Schneider-Gadicke E, Schlimok G, et al. Randomised trial of monoclonal
antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid
17-1A Study Group. Lancet. 1994;343:1177-1183.
191. Rouffet F, Hay JM, Vacher B, et al. Curative resection for left colonic carcinoma:
hemicolectomy vs. segmental colectomy. A prospective, controlled, multicenter trial. French
Association for Surgical Research. Diseases of the colon and rectum. 1994;37:651-659.
192. Sause WT, Pajak TF, Noyes RD, et al. Evaluation of preoperative radiation therapy in
operable colorectal cancer. Annals of surgery. 1994;220:668-675.
193. Seifart W. Technique and results using the glass-rectoscope for tumour resection. Endoscopic
surgery and allied technologies. 1994;2:265-268.
194. Tacke J, Bolder U, Lohlein D. Improved cumulated nitrogen balance after administration of
recombinant human growth hormone in patients undergoing gastrointestinal surgery.
Infusionstherapie und Transfusionsmedizin. 1994;21:24-29.
195. Wang FA, Liao HY, Yan QH. [Scanning electron microscopy of intestinal mucosa after
enteric preparation in patients with carcinoma of large bowel]. Zhonghua wai ke za zhi [Chinese
journal of surgery]. 1994;32:51-52.
196. Weiber S, Graf W, Glimelius B, Jiborn H, Pahlman L, Zederfeldt B. Experimental colonic
healing in relation to timing of 5-fluorouracil therapy. The British journal of surgery.
1994;81:1677-1680.
197. Single-stage treatment for malignant left-sided colonic obstruction: a prospective randomized
clinical trial comparing subtotal colectomy with segmental resection following intraoperative
irrigation. The SCOTIA Study Group. Subtotal Colectomy versus On-table Irrigation and
Anastomosis. The British journal of surgery. 1995;82:1622-1627.
198. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre
Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet. 1995;345:939-944.
199. Altomare DF, Lupo L, Pannarale OC, Di Corcia MG, Memeo V. Reduction of postoperative
immunosuppression with ranitidine in patients with cancer of the stomach or large bowel. The
European journal of surgery = Acta chirurgica. 1995;161:109-113.
200. Arcangeli G, Angelini F, Arcangeli G, et al. A pilot study of concomitant protracted venous
infusion 5-fluorouracil and hyperfractionated radiotherapy in rectal tumors. American journal of
clinical oncology. 1995;18:369-375.
201. Bardram L, Funch-Jensen P, Jensen P, Crawford ME, Kehlet H. Recovery after laparoscopic
colonic surgery with epidural analgesia, and early oral nutrition and mobilisation. Lancet.
1995;345:763-764.
202. Bertsch DJ, Burak WE, Jr., Young DC, Arnold MW, Martin EW, Jr. Radioimmunoguided
Surgery system improves survival for patients with recurrent colorectal cancer. Surgery.
1995;118:634-638; discussion 638-639.
203. Buchmann P, Christen D, Flury R, Luthy A, Bischofberger U. [Does laparoscopic colonic
carcinoma surgery satisfy the radicality criteria of open surgery?]. Schweizerische medizinische
Wochenschrift. 1995;125:1825-1829.
204. Cedermark B, Johansson H, Rutqvist LE, Wilking N. The Stockholm I trial of preoperative
short term radiotherapy in operable rectal carcinoma. A prospective randomized trial. Stockholm
Colorectal Cancer Study Group. Cancer. 1995;75:2269-2275.
205. Ceragioli T, Nervi M, Marrucci G, Marioni A, Giuliani L. [Colorectal carcinoma in the
elderly. Assessment of prognostic factors]. Minerva chirurgica. 1995;50:185-189.
206. Chen FC, Mackay JR, Woods RJ, Collopy BT, Fink RJ, Guiney MJ. Early experience with
postoperative adjuvant chemoradiation for rectal carcinoma: focus on morbidity. The Australian
and New Zealand journal of surgery. 1995;65:732-736.
207. Coucke PA, Sartorelli B, Cuttat JF, Jeanneret W, Gillet M, Mirimanoff RO. The rationale to
switch
from
postoperative
hyperfractionated
accelerated
radiotherapy
to
preoperative
hyperfractionated accelerated radiotherapy in rectal cancer. International journal of radiation
oncology, biology, physics. 1995;32:181-188.
208. D'Agostino G, Scollo MA, Vallo B, Robecchi A. [Current role of abdomino-perineal
amputation]. Minerva chirurgica. 1995;50:325-329.
209. Docherty JG, McGregor JR, Akyol AM, Murray GD, Galloway DJ. Comparison of manually
constructed and stapled anastomoses in colorectal surgery. West of Scotland and Highland
Anastomosis Study Group. Annals of surgery. 1995;221:176-184.
210. Punt CJ, Nagy A, Douillard JY, et al. Edrecolomab alone or in combination with fluorouracil
and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study. Lancet.
2002;360:671-677.
211. Sheen AJ, Poston GJ, Sherlock DJ. Cryotherapeutic ablation of liver tumours. The British
journal of surgery. 2002;89:1396-1401.
212. Staib L, Link KH, Henne-Bruns D. [Interferon-alpha in adjuvant treatment of colorectal
carcinoma]. Kongressband / Deutsche Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur
Chirurgie. Kongress. 2002;119:142-145.
213. Sugiyama Y, Kato T, Nakazato H, et al. Retrospective study on thymidylate synthase as a
predictor of outcome and sensitivity to adjuvant chemotherapy in patients with curatively resected
colorectal cancer. Anti-cancer drugs. 2002;13:931-938.
214. Tepper JE, O'Connell M, Niedzwiecki D, et al. Adjuvant therapy in rectal cancer: analysis of
stage, sex, and local control--final report of intergroup 0114. Journal of clinical oncology : official
journal of the American Society of Clinical Oncology. 2002;20:1744-1750.
215. Uzcudun AE, Batlle JF, Velasco JC, et al. Efficacy of preoperative radiation therapy for
resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with
leucovorin: results from a phase II study. Diseases of the colon and rectum. 2002;45:1349-1358.
216. Vuong T, Belliveau PJ, Michel RP, et al. Conformal preoperative endorectal brachytherapy
treatment for locally advanced rectal cancer: early results of a phase I/II study. Diseases of the
colon and rectum. 2002;45:1486-1493; discussion 1493-1485.
217. Wibe A, Moller B, Norstein J, et al. A national strategic change in treatment policy for rectal
cancer--implementation of total mesorectal excision as routine treatment in Norway. A national
audit. Diseases of the colon and rectum. 2002;45:857-866.
218. Results of a randomized trial with or without 5-FU-based preoperative chemotherapy
followed by postoperative chemotherapy in resected colon and rectal carcinoma. Japanese journal
of clinical oncology. 2003;33:288-296.
219. Arkenau HT, Bermann A, Rettig K, Strohmeyer G, Porschen R. 5-Fluorouracil plus
leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer:
long-term follow-up results of the adjCCA-01 trial. Annals of oncology : official journal of the
European Society for Medical Oncology / ESMO. 2003;14:395-399.
220. Cafiero F, Gipponi M, Lionetto R. Randomised clinical trial of adjuvant postoperative RT vs.
sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal
cancer: a final report. Journal of surgical oncology. 2003;83:140-146.
221. Cazacu M, Oniu T, Lungoci C, et al. The influence of isorel on the advanced colorectal
cancer. Cancer biotherapy & radiopharmaceuticals. 2003;18:27-34.
222. Di Costanzo F, Sobrero A, Gasperoni S, et al. Adjuvant chemotherapy in the treatment of
colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant
Chemotherapy in Colon Cancer (INTACC). Annals of oncology : official journal of the European
Society for Medical Oncology / ESMO. 2003;14:1365-1372.
223. Feliciotti F, Guerrieri M, Paganini AM, et al. Long-term results of laparoscopic versus open
resections for rectal cancer for 124 unselected patients. Surgical endoscopy. 2003;17:1530-1535.
224. Gerard JP, Chapet O, Nemoz C, et al. Preoperative concurrent chemoradiotherapy in locally
advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon
R0-04 phase II trial. Journal of clinical oncology : official journal of the American Society of
Clinical Oncology. 2003;21:1119-1124.
225. Isomoto H, Tomita M, Sugimachi K, et al. Pre- and post-operative adjuvant chemotherapy in
colorectal cancer. International journal of oncology. 2003;23:1103-1108.
226. Kim DJ, Kim TI, Suh JH, et al. Oral tegafur-uracil plus folinic acid versus intravenous
5-fluorouracil plus folinic acid as adjuvant chemotherapy of colon cancer. Yonsei medical journal.
2003;44:665-675.
227. Koda K, Miyazaki M, Sarashina H, et al. A randomized controlled trial of postoperative
adjuvant immunochemotherapy for colorectal cancer with oral medicines. International journal of
oncology. 2003;23:165-172.
228. Kuechler A, Dreidax M, Pigorsch SU, et al. Residual chromosomal damage after
radiochemotherapy with and without amifostine detected by 24-color FISH. Strahlentherapie und
Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 2003;179:493-498.
229. Lorenz M, Staib-Sebler E, Gog C, et al. Prospective pilot study of neoadjuvant chemotherapy
with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer.
Analysis of 42 neoadjuvant chemotherapies. Zentralblatt fur Chirurgie. 2003;128:87-94.
230. Malinovskii NN, Severtsev AN, Smirnova NB. [Cytoreductive surgery of liver metastasis
from colorectal cancer: principles of intra-arterial regional chemotherapy]. Khirurgiia.
2003:14-21.
231. Meyerhardt JA, Catalano PJ, Haller DG, et al. Impact of diabetes mellitus on outcomes in
patients with colon cancer. Journal of clinical oncology : official journal of the American Society
of Clinical Oncology. 2003;21:433-440.
232. Pilati P, Mocellin S, Rossi CR, et al. Cytoreductive surgery combined with hyperthermic
intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon
adenocarcinoma. Annals of surgical oncology. 2003;10:508-513.
233. Sakamoto J, Hamashima H, Suzuki H, et al. Thymidylate synthase expression as a predictor
of the prognosis of curatively resected colon carcinoma in patients registered in an adjuvant
immunochemotherapy clinical trial. Oncology reports. 2003;10:1081-1090.
234. Sauer R, Fietkau R, Wittekind C, et al. Adjuvant vs. neoadjuvant radiochemotherapy for
locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal disease : the
official journal of the Association of Coloproctology of Great Britain and Ireland. 2003;5:406-415.
235. Scaife CL, Curley SA, Izzo F, et al. Feasibility of adjuvant hepatic arterial infusion of
chemotherapy after radiofrequency ablation with or without resection in patients with hepatic
metastases from colorectal cancer. Annals of surgical oncology. 2003;10:348-354.
236. Scheithauer W, McKendrick J, Begbie S, et al. Oral capecitabine as an alternative to i.v.
5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III
trial. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO.
2003;14:1735-1743.
237. Tepper JE, O'Connell M, Hollis D, Niedzwiecki D, Cooke E, Mayer RJ. Analysis of surgical
salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2003;21:3623-3628.
238. Voelter V, Stupp R, Matter M, et al. Preoperative hyperfractionated accelerated radiotherapy
(HART) and concomitant CPT-11 in locally advanced rectal carcinoma: a phase I study.
International journal of radiation oncology, biology, physics. 2003;56:1288-1294.
239. Zelek L, Bugat R, Cherqui D, et al. Multimodal therapy with intravenous biweekly
leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in
non-resectable hepatic metastases from colorectal cancer (a European Association for Research in
Oncology trial). Annals of oncology : official journal of the European Society for Medical
Oncology / ESMO. 2003;14:1537-1542.
240. Zhuchenko AP, Kalganov ID, Filon AF. [Cytoreductive surgery with intraperitoneal
chemotherapy in patients with colon cancer and peritoneal carcinomatosis]. Antibiotiki i
khimioterapiia
=
Antibiotics
and
chemoterapy
[sic]
/
Ministerstvo
meditsinskoi
i
mikrobiologicheskoi promyshlennosti SSSR. 2003;48:31-35.
241. Amthauer H, Denecke T, Rau B, et al. Response prediction by FDG-PET after neoadjuvant
radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with
endorectal ultrasound and histopathology. European journal of nuclear medicine and molecular
imaging. 2004;31:811-819.
242. Bathe OF, Dowden S, Sutherland F, et al. Phase II study of neoadjuvant 5-FU + leucovorin +
CPT-11 in patients with resectable liver metastases from colorectal adenocarcinoma. BMC cancer.
2004;4:32.
243. Bosset JF, Calais G, Daban A, et al. Preoperative chemoradiotherapy versus preoperative
radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance.
Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. European
journal of cancer (Oxford, England : 1990). 2004;40:219-224.
244. Burmeister BH, Schache D, Burmeister EA, et al. Synchronous postoperative adjuvant
chemoradiation therapy for locally advanced carcinoma of the rectum. International journal of
colorectal disease. 2004;19:55-59.
245. Charara M, Edmonston TB, Burkholder S, et al. Microsatellite status and cell cycle
associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11
chemotherapy and radiotherapy. Anticancer research. 2004;24:3161-3167.
246. Chau I, Allen MJ, Cunningham D, et al. The value of routine serum carcino-embryonic
antigen measurement and computed tomography in the surveillance of patients after adjuvant
chemotherapy for colorectal cancer. Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2004;22:1420-1429.
247. Cheng J, Hong D, Zhu G, Swanstrom LL, Hansen PD. Laparoscopic placement of hepatic
artery infusion pumps: technical considerations and early results. Annals of surgical oncology.
2004;11:589-597.
248. Elias D, Delperro JR, Sideris L, et al. Treatment of peritoneal carcinomatosis from colorectal
cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials.
Annals of surgical oncology. 2004;11:518-521.
249. Fernandez-Martos C, Aparicio J, Bosch C, et al. Preoperative uracil, tegafur, and concomitant
radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-Up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2004;22:3016-3022.
250. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with
perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from
colorectal cancer: a multi-institutional study. Journal of clinical oncology : official journal of the
American Society of Clinical Oncology. 2004;22:3284-3292.
251. Inoue Y, Shirane M, Miki C, et al. Gene expression profiles of colorectal carcinoma in
response to neo-adjuvant chemotherapy. International journal of oncology. 2004;25:1641-1649.
252. Ito K, Okushiba S, Morikawa T, Kondo S, Katoh H. [Appropriate duration of postoperative
oral adjuvant chemotherapy with HCFU for colorectal cancer]. Gan to kagaku ryoho. Cancer &
chemotherapy. 2004;31:55-59.
253. Ji ZL, Peng SY, Yuan AJ, Li PJ, Zhang W, Yu Y. Hepatic resection for metastasis from
colorectal cancer. Techniques in coloproctology. 2004;8 Suppl 1:s47-49.
254. Martenson JA, Jr., Willett CG, Sargent DJ, et al. Phase III study of adjuvant chemotherapy
and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of
colon cancer: results of intergroup protocol 0130. Journal of clinical oncology : official journal of
the American Society of Clinical Oncology. 2004;22:3277-3283.
255. Masi G, Allegrini G, Cupini S, et al. First-line treatment of metastatic colorectal cancer with
irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study
with a simplified biweekly schedule. Annals of oncology : official journal of the European Society
for Medical Oncology / ESMO. 2004;15:1766-1772.
256. Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D. Posttreatment TNM staging is a
prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after
preoperative chemotherapy and radiotherapy. International journal of radiation oncology, biology,
physics. 2005;61:665-677.
257. Chau I, Norman AR, Cunningham D, et al. A randomised comparison between 6 months of
bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant
treatment in colorectal cancer. Annals of oncology : official journal of the European Society for
Medical Oncology / ESMO. 2005;16:549-557.
258. De Placido S, Lopez M, Carlomagno C, et al. Modulation of 5-fluorouracil as adjuvant
systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III
study. British journal of cancer. 2005;93:896-904.
259. Delaunoit T, Alberts SR, Sargent DJ, et al. Chemotherapy permits resection of metastatic
colorectal cancer: experience from Intergroup N9741. Annals of oncology : official journal of the
European Society for Medical Oncology / ESMO. 2005;16:425-429.
260. Elias D, Baton O, Sideris L, et al. Hepatectomy plus intraoperative radiofrequency ablation
and chemotherapy to treat technically unresectable multiple colorectal liver metastases. Journal of
surgical oncology. 2005;90:36-42.
261. Farkas E. [Fermented wheat germ extract in the supportive therapy of colorectal cancer].
Orvosi hetilap. 2005;146:1925-1931.
262. Fischer F, Mirow L, Gondeck C, Schwandner O, Bruch HP, Farke S. [Influence of adjuvant
radio-chemotherapy for rectal cancer on quality of life]. Zeitschrift fur Gastroenterologie.
2005;43:1213-1218.
263. Giralt J, de las Heras M, Cerezo L, et al. The expression of epidermal growth factor receptor
results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy:
a multicenter, retrospective analysis. Radiotherapy and oncology : journal of the European Society
for Therapeutic Radiology and Oncology. 2005;74:101-108.
264. Kawai K, Watabe S, Matsuda M, Sakamoto K, Kamano T. Correlation between expression of
orotate phosphoribosyl transferase and 5-fluorouracil sensitivity, as measured by apoptosis index
in colorectal cancer tissue. International journal of gastrointestinal cancer. 2005;35:197-203.
265. Kusunoki M, Ikeuchi H, Yanagi H, et al. Bioresorbable hyaluronate-carboxymethylcellulose
membrane (Seprafilm) in surgery for rectal carcinoma: a prospective randomized clinical trial.
Surgery today. 2005;35:940-945.
266. Luo KY, Shao QH, Yang GK, et al. [125I seed implantation in sphincter preservation for
treatment of low rectal cancer]. Zhonghua yi xue za zhi. 2005;85:1355-1357.
267. Lupattelli M, Maranzano E, Bellavita R, et al. Raltitrexed and radiotherapy as adjuvant
treatment for stage II-III rectal cancer: a feasibility study. Tumori. 2005;91:498-504.
268. Niloofar A, Mosalaei A, Shapour O, Mohammadianpanah M. Role of external irradiation in
high-risk resected colon cancer. Indian journal of cancer. 2005;42:133-137.
269. Nordlinger B, Rougier P, Arnaud JP, et al. Adjuvant regional chemotherapy and systemic
chemotherapy versus systemic chemotherapy alone in patients with stage II-III colorectal cancer: a
multicentre randomised controlled phase III trial. The lancet oncology. 2005;6:459-468.
270. Rengan R, Paty P, Wong WD, et al. Distal cT2N0 rectal cancer: is there an alternative to
abdominoperineal resection? Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2005;23:4905-4912.
271. Sadahiro S, Mitomi T, Noto T, et al. [Multicenter comparative study of the
recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer
following curative resection]. Gan to kagaku ryoho. Cancer & chemotherapy. 2005;32:997-1005.
272. Taieb J, Artru P, Paye F, et al. Intensive systemic chemotherapy combined with surgery for
metastatic colorectal cancer: results of a phase II study. Journal of clinical oncology : official
journal of the American Society of Clinical Oncology. 2005;23:502-509.
273. Takahashi Y, Mai M, Nakazato H. Preoperative CEA and PPD values as prognostic factors
for immunochemotherapy using PSK and 5-FU. Anticancer research. 2005;25:1377-1384.
274. Turrini O, Guiramand J, Moutardier V, et al. [Major hepatectomy for metastasis of colorectal
cancer improves survival in the elderly]. Annales de chirurgie. 2005;130:562-565.
275. Akasu T, Moriya Y, Ohashi Y, Yoshida S, Shirao K, Kodaira S. Adjuvant chemotherapy with
uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective
lateral pelvic lymphadenectomy: a multicenter randomized controlled trial. Japanese journal of
clinical oncology. 2006;36:237-244.
276. Benoist S, Brouquet A, Penna C, et al. Complete response of colorectal liver metastases after
chemotherapy: does it mean cure? Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2006;24:3939-3945.
277. Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal
cancer. The New England journal of medicine. 2006;355:1114-1123.
278. Elias D, Raynard B, Farkhondeh F, et al. Peritoneal carcinomatosis of colorectal origin.
Gastroenterologie clinique et biologique. 2006;30:1200-1204.
279. Gan JL, Guo Y, Tang ZJ, Gao F, Tang WZ, Liu XJ. [Influence and significance of
preoperative intraarterial infusion chemotherapy combined with radiotherapy on survivin, p53 and
Bax expression in low rectal carcinoma]. Ai zheng = Aizheng = Chinese journal of cancer.
2006;25:1423-1427.
280. Hildebrandt B, Rau B, Loffel J, et al. Adjuvant chemotherapy with folinic acid and
5-fluorouracil in patients with locally advanced rectal cancer previously treated by preoperative
radiochemotherapy and curative tumor resection. International journal of colorectal disease.
2006;21:582-589.
281. Klenova A, Parvanova V, Georgiev R, Gesheva N. Preoperative radiotherapy in rectal cancer:
treatment results of three different dose regimens. Journal of B.U.ON. : official journal of the
Balkan Union of Oncology. 2006;11:161-166.
282. Krempien R, Roeder F, Oertel S, et al. Long-term results of intraoperative presacral electron
boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and
chemoradiation in patients with locally advanced rectal cancer. International journal of radiation
oncology, biology, physics. 2006;66:1143-1151.
283. Luo L, Yang YF, Li PH. [Cohort study on fuzheng capsule and quxie capsule in reducing
relapse and metastasis of cancer in patients with stage II and III colorectal carcinoma after
operation]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal
of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo
Zhong yi yan jiu yuan zhu ban. 2006;26:677-680.
284. Martin RC, 2nd, Scoggins CR, McMasters KM. A phase II study of radiofrequency ablation
of unresectable metastatic colorectal cancer with hepatic arterial infusion pump chemotherapy.
Journal of surgical oncology. 2006;93:387-393.
285. Masi G, Cupini S, Marcucci L, et al. Treatment with 5-fluorouracil/folinic acid, oxaliplatin,
and irinotecan enables surgical resection of metastases in patients with initially unresectable
metastatic colorectal cancer. Annals of surgical oncology. 2006;13:58-65.
286. Movsas B, Diratzouian H, Hanlon A, et al. Phase II trial of preoperative chemoradiation with
a hyperfractionated radiation boost in locally advanced rectal cancer. American journal of clinical
oncology. 2006;29:435-441.
287. O'Connell MJ, Sargent DJ, Windschitl HE, et al. Randomized clinical trial of high-dose
levamisole combined with 5-fluorouracil and leucovorin as surgical adjuvant therapy for high-risk
colon cancer. Clinical colorectal cancer. 2006;6:133-139.
288. Portier G, Elias D, Bouche O, et al. Multicenter randomized trial of adjuvant fluorouracil and
folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD
ACHBTH AURC 9002 trial. Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2006;24:4976-4982.
289. Pucciarelli S, Urso E, DeSalvo GL, et al. 5-fluorouracil and weekly oxaliplatin combined
with radiotherapy for locally advanced rectal cancer: surgical complications and long-term results.
Archives of medical research. 2006;37:860-865.
290. Sadahiro S, Suzuki T, Maeda Y, Makuuchi H, Murayama C. [Feasibility of
weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy
for colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 2006;33:333-336.
291. Smalley SR, Benedetti JK, Williamson SK, et al. Phase III trial of fluorouracil-based
chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2006;24:3542-3547.
292. Suwinski R, Wydmanski J, Pawelczyk I, Starzewski J. A pilot study of accelerated
preoperative hyperfractionated pelvic irradiation with or without low-dose preoperative
prophylactic liver irradiation in patients with locally advanced rectal cancer. Radiotherapy and
oncology : journal of the European Society for Therapeutic Radiology and Oncology.
2006;80:27-32.
293. Taher AN, El-Baradie MM, Nasr AM, et al. Locally advanced rectal carcinoma: preoperative
radiotherapy versus postoperative chemoradiation, 10-year follow-up results of a randomized
clinical study. Journal of the Egyptian National Cancer Institute. 2006;18:233-243.
294. Urso E, Serpentini S, Pucciarelli S, et al. Complications, functional outcome and quality of
life after intensive preoperative chemoradiotherapy for rectal cancer. European journal of surgical
oncology : the journal of the European Society of Surgical Oncology and the British Association
of Surgical Oncology. 2006;32:1201-1208.
295. Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyperfractionated
chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A
multicentric phase II study. International journal of radiation oncology, biology, physics.
2006;64:1129-1139.
296. Watanabe M, Kodaira S, Takahashi T, et al. Randomized trial of the efficacy of adjuvant
chemotherapy for colon cancer with combination therapy incorporating the oral pyrimidine
1-hexylcarbamoyl-5-fluorouracil. Langenbeck's archives of surgery / Deutsche Gesellschaft fur
Chirurgie. 2006;391:330-337.
297. Xu JM, Zhong YS, Niu WX, et al. [Preoperative hepatic and regional arterial infusion
chemotherapy in the prevention of liver metastasis after colorectal cancer surgery]. Zhonghua yi
xue za zhi. 2006;86:88-92.
298. Abitabile P, Hartl U, Lange J, Maurer CA. Radiofrequency ablation permits an effective
treatment for colorectal liver metastasis. European journal of surgical oncology : the journal of the
European Society of Surgical Oncology and the British Association of Surgical Oncology.
2007;33:67-71.
299. Allen SD, Padhani AR, Dzik-Jurasz AS, Glynne-Jones R. Rectal carcinoma: MRI with
histologic correlation before and after chemoradiation therapy. AJR. American journal of
roentgenology. 2007;188:442-451.
300. Lanuke K, Mack LA, Temple WJ. Phase II study of regional treatment for peritoneal
carcinomatosis. American journal of surgery. 2009;197:614-618; discussion 618.
301. Lin CP, Chi P. [Clinical study of postoperative intraperitoneal chemotherapy combined with
systemic chemotherapy for serosa-involved colorectal cancer]. Zhonghua wei chang wai ke za zhi
= Chinese journal of gastrointestinal surgery. 2009;12:257-260.
302. Matsuoka H, Masaki T, Takayama M, et al. Impact of intra-operative radiotherapy on
evacuatory function following ultra-low anterior resection. A preliminary result of prospective
randomized trial. Hepato-gastroenterology. 2009;56:1656-1660.
303. Nguyen KT, Laurent A, Dagher I, et al. Minimally invasive liver resection for metastatic
colorectal cancer: a multi-institutional, international report of safety, feasibility, and early
outcomes. Annals of surgery. 2009;250:842-848.
304. Parc Y, Zutshi M, Zalinski S, Ruppert R, Furst A, Fazio VW. Preoperative radiotherapy is
associated with worse functional results after coloanal anastomosis for rectal cancer. Diseases of
the colon and rectum. 2009;52:2004-2014.
305. Roh MS, Colangelo LH, O'Connell MJ, et al. Preoperative multimodality therapy improves
disease-free survival in patients with carcinoma of the rectum: NSABP R-03. Journal of clinical
oncology : official journal of the American Society of Clinical Oncology. 2009;27:5124-5130.
306. Siegel R, Burock S, Wernecke KD, et al. Preoperative short-course radiotherapy versus
combined radiochemotherapy in locally advanced rectal cancer: a multi-centre prospectively
randomised study of the Berlin Cancer Society. BMC cancer. 2009;9:50.
307. Bellmunt J, Albanell J, Paz-Ares L, et al. Pretreatment prognostic factors for survival in
patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and
gemcitabine. Cancer. 2002;95:751-757.
308. Bellmunt J, Choueiri TK, Fougeray R, et al. Prognostic factors in patients with advanced
transitional cell carcinoma of the urothelial tract experiencing treatment failure with
platinum-containing regimens. Journal of clinical oncology : official journal of the American
Society of Clinical Oncology. 2010;28:1850-1855.
309. Benavides M, Pericay C, Valladares-Ayerbes M, et al. Oxaliplatin in combination with
infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal
cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumors.
Clinical colorectal cancer. 2012;11:200-206.
310. Ben-Baruch N, Denicoff AM, Goldspiel BR, O'Shaughnessy JA, Cowan KH. Phase II study
of fazarabine (NSC 281272) in patients with metastatic colon cancer. Investigational new drugs.
1993;11:71-74.
311. Bender H, Bangard N, Metten N, et al. Possible role of FDG-PET in the early prediction of
therapy outcome in liver metastases of colorectal cancer. Hybridoma. 1999;18:87-91.
312. Benevento A, Dominioni L, Carcano G, Dionigi R. Intraoperative localization of gut
endocrine tumors with radiolabeled somatostatin analogs and a gamma-detecting probe. Seminars
in surgical oncology. 1998;15:239-244.
313. Brown J, Perilongo G, Shafford E, et al. Pretreatment prognostic factors for children with
hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study
SIOPEL 1. European journal of cancer (Oxford, England : 1990). 2000;36:1418-1425.
314. Homayounfar K, Bleckmann A, Conradi LC, et al. Bilobar spreading of colorectal liver
metastases does not significantly affect survival after R0 resection in the era of interdisciplinary
multimodal treatment. International journal of colorectal disease. 2012;27:1359-1367.
315. Homayounfar K, Liersch T, Schuetze G, et al. Two-stage hepatectomy (R0) with portal vein
ligation--towards curing patients with extended bilobular colorectal liver metastases. International
journal of colorectal disease. 2009;24:409-418.
316. Sadahiro S, Ohki S, Yamaguchi S,
et al. [Optimal dosage of UFT in a
weekday-on/weekend-off schedule as a postoperative adjuvant chemotherapy for colorectal
cancer]. Gan to kagaku ryoho. Cancer & chemotherapy. 2000;27:2223-2230.
317. Sadahiro S, Ohki S, Yamaguchi S, et al. Feasibility of a novel weekday-on/weekend-off oral
UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer. UFT Compliance
Study Group, Kanagawa, Japan. Cancer chemotherapy and pharmacology. 2000;46:180-184.
318. Sauer R, Fietkau R, Wittekind C, et al. Adjuvant versus neoadjuvant radiochemotherapy for
locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol
CAO/ARO/AIO-94).
Strahlentherapie
und
Onkologie
:
Organ
der
Deutschen
Rontgengesellschaft ... [et al]. 2001;177:173-181.
319. Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for
locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III
trial after a median follow-up of 11 years. Journal of clinical oncology : official journal of the
American Society of Clinical Oncology. 2012;30:1926-1933.
320. Scheithauer W, Kornek G, Rosen H, et al. Combined intraperitoneal plus intravenous
chemotherapy after curative resection for colonic adenocarcinoma. European journal of cancer
(Oxford, England : 1990). 1995;31A:1981-1986.
321. Scheithauer W, Kornek GV, Marczell A, et al. Combined intravenous and intraperitoneal
chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of
resected colon carcinoma. British journal of cancer. 1998;77:1349-1354.
322. Schmitt G, Pape H, Neu A, Zamboglou N. [Value of radiotherapy in the interdisciplinary
therapeutic treatment concept of rectal cancer]. Der Radiologe. 1986;26:381-384.
323. Schrag D, Weiser MR, Goodman KA, et al. Neoadjuvant chemotherapy without routine use
of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. Journal of
clinical oncology : official journal of the American Society of Clinical Oncology.
2014;32:513-518.
324. Schultheis KH, Gebhardt C, Schwemmle K, Richter EI, Schumacher F. [Chemoembolization
of colorectal liver metastases]. Zentralblatt fur Chirurgie. 1990;115:933-947.
325. Sertoli MR, Guarneri D, Rubagotti A, Porcile G, Nobile MT, Rosso R. Adjuvant
immunochemotherapy in colorectal cancer Dukes C. Oncology. 1987;44:78-81.
326. Shen P, Thai K, Stewart JH, et al. Peritoneal surface disease from colorectal cancer:
comparison with the hepatic metastases surgical paradigm in optimally resected patients. Annals
of surgical oncology. 2008;15:3422-3432.
327. Shimada H, Ozaki M, Ariga T, et al. [Experience in intra-hepatic-arterial chemotherapy and
hepatic resection for metastatic colorectal cancer]. Gan to kagaku ryoho. Cancer & chemotherapy.
1995;22:1570-1572.
328. Sinicrope FA, Mahoney MR, Smyrk TC, et al. Prognostic impact of deficient DNA mismatch
repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant
chemotherapy. Journal of clinical oncology : official journal of the American Society of Clinical
Oncology. 2013;31:3664-3672.
329. Smeenk RM, Verwaal VJ, Zoetmulder FA. Learning curve of combined modality treatment in
peritoneal surface disease. The British journal of surgery. 2007;94:1408-1414.
330. Smith R, Wickerham DL, Wieand HS, Colangelo L, Mamounas EP. UFT plus calcium
folinate vs 5-FU plus calcium folinate in colon cancer. Oncology (Williston Park, N.Y.).
1999;13:44-47.
331. Smith RE, Colangelo L, Wieand HS, Begovic M, Wolmark N. Randomized trial of adjuvant
therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Journal of the National
Cancer Institute. 2004;96:1128-1132.
332. Smith RE, Lembersky BC, Wieand HS, Colangelo L, Mamounas EP. UFT/leucovorin vs
5-FU/leucovorin in colon cancer. Oncology (Williston Park, N.Y.). 2000;14:24-27.
333. Sparso BH, Von der Maase H, Kristensen D, et al. Complications following postoperative
combined radiation and chemotherapy in adenocarcinoma of the rectum and rectosigmoid. A
randomized trial that failed. Cancer. 1984;54:2363-2366.
334. Staib L, Link KH, Beger HG. Toxicity and effects of adjuvant therapy in colon cancer: results
of the German prospective, controlled randomized multicenter trial FOGT-1. Journal of
gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
2001;5:275-281.
335. Stein A, Glockzin G, Wienke A, et al. Treatment with bevacizumab and FOLFOXIRI in
patients with advanced colorectal cancer: presentation of two novel trials (CHARTA and
PERIMAX) and review of the literature. BMC cancer. 2012;12:356.
336. Steinberg SM, Barwick KW, Stablein DM. Importance of tumor pathology and morphology
in patients with surgically resected colon cancer. Findings from the Gastrointestinal Tumor Study
Group. Cancer. 1986;58:1340-1345.
337. Strocchi E, Iaffaioli RV, Facchini G, et al. Stop-flow technique for loco-regional delivery of
high dose chemotherapy in the treatment of advanced pelvic cancers. European journal of surgical
oncology : the journal of the European Society of Surgical Oncology and the British Association
of Surgical Oncology. 2004;30:663-670.
338. Sugimachi K, Maehara Y, Ogawa M, Kakegawa T, Tomita M, Akiyoshi T. Postoperative
chemotherapy
for
colorectal
cancer
by
combining
5-fluorouracil
infusion
and
1-hexylcarbamoyl-5-fluorouracil administration after curative resection. Cancer. 1996;77:36-43.
339. Sun N, Cai Z, Zhang C. [Early postoperative intraperitoneal perfusion chemotherapy for
advanced colorectal cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology].
1998;20:222-224.
340. Suzuka I, Izumi S, Onoda Y, et al. [Usefulness of pharmacokinetic modulating chemotherapy
(PMC) for the postoperative adjuvant therapy of colorectal carcinoma: a preliminary report]. Gan
to kagaku ryoho. Cancer & chemotherapy. 1999;26:2183-2188.
341. Szynglarewicz B, Matkowski R, Halon A, et al. Association between histological type of
tumour growth and patient survival in t2-t3 lymph node-negative rectal cancer treated with
sphincter-preserving
total
mesorectal
excision. Pathology oncology research
: POR.
2010;16:201-206.
342. Takahashi T, Kato T, Kodaira S, et al. Prognostic factors of colorectal cancer. Results of
multivariate analysis of curative resection cases with or without adjuvant chemotherapy. American
journal of clinical oncology. 1996;19:408-415.
343. Takashima S, Kinami Y, Miyazaki I. [Clinical effect of postoperative adjuvant
immunochemotherapy with the FT-207 suppository and PSK in colorectal cancer patients.
Colorectal Cancer Chemotherapy Group in Hokuriku]. Gan to kagaku ryoho. Cancer &
chemotherapy. 1988;15:2229-2236.
344. Takashima S, Kosaka T, Ueno K, Fujita H, Miyazaki I. [Evaluation of preoperative
administration of N1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) suppository in surgical adjuvant
chemotherapy for large bowel cancer]. Gan to kagaku ryoho. Cancer & chemotherapy.
1984;11:2362-2371.
345. Takashima S, Tomita F, Saito H, et al. [Clinical effect of postoperative adjuvant
chemotherapy for advanced colorectal cancer--comparisons of between tegafur (FT) and UFT].
Gan to kagaku ryoho. Cancer & chemotherapy. 1991;18:2315-2324.
346. Takebayashi K, Mekata E, Sonoda H, et al. Differences in chemosensitivity between primary
and metastatic tumors in colorectal cancer. PloS one. 2013;8:e73215.
347. Takenoue T, Nagawa H, Matsuda K, et al. Relation between thymidylate synthase expression
and survival in colon carcinoma, and determination of appropriate application of 5-fluorouracil by
immunohistochemical method. Annals of surgical oncology. 2000;7:193-198.
348. Takii Y, Shimada Y, Moriya Y, et al. A randomized controlled trial of the conventional
technique versus the no-touch isolation technique for primary tumor resection in patients with
colorectal cancer: Japan Clinical Oncology Group Study JCOG1006. Japanese journal of clinical
oncology. 2014;44:97-100.
349. Tang YQ, Tan ZM, Wang JK, et al. [Preoperative intra-arterial chemotherapy for progressive
lower rectal cancer]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University.
2008;28:1247-1248.
350. Taucher S, Steger GG, Jakesz R, et al. The potential risk of neoadjuvant chemotherapy in
breast cancer patients--results from a prospective randomized trial of the Austrian Breast and
Colorectal Cancer Study Group (ABCSG-07). Breast cancer research and treatment.
2008;112:309-316.
351. Tentes AA, Mirelis C, Karanikiotis C, Korakianitis O. Radical lymph node resection of the
retroperitoneal area for left-sided colon cancer. Langenbeck's archives of surgery / Deutsche
Gesellschaft fur Chirurgie. 2007;392:155-160.
352. Tepper JE, O'Connell MJ, Petroni GR, et al. Adjuvant postoperative fluorouracil-modulated
chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of
intergroup 0114. Journal of clinical oncology : official journal of the American Society of Clinical
Oncology. 1997;15:2030-2039.
353. Terabe K, Yamauchi M, Watanabe T, et al. [Prospective adjuvant chemotherapy, with
mitomycin C plus long-term carmofur in colorectal cancer]. Gan no rinsho. Japan journal of
cancer clinics. 1986;32:261-267.
354. Tevis SE, Kohlnhofer BM, Stringfield S, et al. Postoperative complications in patients with
rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and
overall survival. Diseases of the colon and rectum. 2013;56:1339-1348.
355. Thomas PR, Lindblad AS. Adjuvant postoperative radiotherapy and chemotherapy in rectal
carcinoma: a review of the Gastrointestinal Tumor Study Group experience. Radiotherapy and
oncology : journal of the European Society for Therapeutic Radiology and Oncology.
1988;13:245-252.
356. Thomas PR, Stablein DM, Kinzie JJ, et al. Perineal effects of postoperative treatment for
adenocarcinoma of the rectum. International journal of radiation oncology, biology, physics.
1986;12:167-171.
357. Thomas PR, Stablein DM, Steinberg SM, Barkin JS, Nauta RJ. The effects of liver directed
radiotherapy and chemotherapy on liver function tests and hematological parameters in patients
with surgically resected colon cancer: findings from the Gastrointestinal Tumor Study Group. The
American journal of gastroenterology. 1987;82:738-743.
358. Tominaga T, Sakabe T, Koyama Y, et al. Prognostic factors for patients with colon or rectal
carcinoma treated with resection only. Five-year follow-up report. Cancer. 1996;78:403-408.
359. Tsavaris N, Gennatas K, Kosmas C, et al. Leucovorin and fluorouracil vs levamisole and
fluorouracil as adjuvant chemotherapy in rectal cancer. Oncology reports. 2004;12:927-932.
360. Tsilimparis N, Bockelmann C, Raue W, et al. Quality of life in patients after cytoreductive
surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk? Annals of surgical
oncology. 2013;20:226-232.
361. Tu SL, Yuan JH, Deng GL, et al. [Study of prophylactic intra-iliac and hepatic arterial
infusion chemotherapy against pelvic recurrence and liver metastasis after radical resection for
rectal cancer]. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.
2007;10:149-152.
362. Uehara K, Hiramatsu K, Maeda A, et al. Neoadjuvant oxaliplatin and capecitabine and
bevacizumab without radiotherapy for poor-risk rectal cancer: N-SOG 03 Phase II trial. Japanese
journal of clinical oncology. 2013;43:964-971.
363. Uehara K, Maeda A, Sakamoto E, et al. Phase II trial of adjuvant chemotherapy with S-1 for
colorectal liver metastasis. Annals of surgical oncology. 2013;20:475-481.
364. Uematsu T, Nakashima M, Fujii M, et al. Measurement of 5-fluorouracil in scalp hair: a
possible index of patient compliance with oral adjuvant chemotherapy. European journal of
clinical pharmacology. 1996;50:109-113.
365. Valencia J, Esco R, Polo S, Bascon N, Escudero P, Alonso V. Postoperative
radiochemotherapy in rectal cancer comparison of two combination schemes: alternating versus
concomitant. Tumori. 2004;90:216-224.
366. Watanabe M, Nishida O, Kunii Y, et al. Randomized controlled trial of the efficacy of
adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different
combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines
1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur. International journal of clinical oncology.
2004;9:98-106.
367. Weber W, Maibach R, Laffer U, et al. Early hematological toxicity of adjuvant perioperative
intraportal and intravenous chemotherapy with fluorouracil, mitomycin and heparin in colorectal
cancer. Swiss Group for Clinical Cancer Research. Anticancer research. 1995;15:2197-2200.
368. Weber W, Metzger U, Laffer U, Egeli R. Hematological toxicity of adjuvant portal liver
infusion with fluorouracil, mitomycin and heparin. Anticancer research. 1991;11:365-368.
369. Weiss RB, DeVita VT, Jr. The dilemma regarding postoperative chemotherapy in primary
carcinoma of the colon. Surgery, gynecology & obstetrics. 1979;149:267-271.
370. Willett CG, Goldberg S, Shellito PC, et al. Does postoperative irradiation play a role in the
adjuvant therapy of stage T4 colon cancer? The cancer journal from Scientific American.
1999;5:242-247.
371. Wolmark N, Fisher B, Rockette H, et al. Postoperative adjuvant chemotherapy or BCG for
colon cancer: results from NSABP protocol C-01. Journal of the National Cancer Institute.
1988;80:30-36.
372. Wolmark N, Rockette H, Wickerham DL, et al. Adjuvant therapy of Dukes' A, B, and C
adenocarcinoma of the colon with portal-vein fluorouracil hepatic infusion: preliminary results of
National Surgical Adjuvant Breast and Bowel Project Protocol C-02. Journal of clinical oncology :
official journal of the American Society of Clinical Oncology. 1990;8:1466-1475.
373. Wolmark N, Wieand HS, Hyams DM, et al. Randomized trial of postoperative adjuvant
chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical
Adjuvant Breast and Bowel Project Protocol R-02. Journal of the National Cancer Institute.
2000;92:388-396.
374. Wright JC. Update in cancer chemotherapy: gastrointestinal cancer--colorectal cancer, Part 2.
Journal of the National Medical Association. 1986;78:395-408.
375. Wu JG, Huang WZ, Wu BY. [Effect of acupoint irradiation with Q-wave millimeter
microwave on peripheral white blood cells in post-operational treatment with chemotherapy in
stomach and colorectal cancer patients]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi
jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi
yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban. 1997;17:286-288.
376. Yamada Y, Takahari D, Matsumoto H, et al. Leucovorin, fluorouracil, and oxaliplatin plus
bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal
cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial. The lancet oncology.
2013;14:1278-1286.
377. Yamaguchi A, Maeda A, Hachisuka K, et al. [Study of 5'-DFUR treatment as postoperative
adjuvant chemotherapy for stomach and colorectal cancer. Tokai GATS Group (pilot study)]. Gan
to kagaku ryoho. Cancer & chemotherapy. 1994;21:621-626.
378. Yang XJ, Li Y, al-shammaa Hassan AH, et al. Cytoreductive surgery plus hyperthermic
intraperitoneal
chemotherapy improves
survival
in
selected
patients
with
peritoneal
carcinomatosis from abdominal and pelvic malignancies: results of 21 cases. Annals of surgical
oncology. 2009;16:345-351.
379. Yasutomi M, Takahashi T, Kodaira S, et al. [Prospective controlled study on the usefulness of
Carmofur as a postoperative adjuvant chemotherapy for colorectal cancer]. Gan to kagaku ryoho.
Cancer & chemotherapy. 1997;24:1953-1960.
380. Yau T, Watkins D, Cunningham D, Barbachano Y, Chau I, Chong G. Longitudinal assessment
of quality of life in rectal cancer patients with or without stomas following primary resection.
Diseases of the colon and rectum. 2009;52:669-677.
381. Yoon WS, Park W, Choi DH, et al. Which patients benefit from preoperative
chemoradiotherapy for intermediate staged rectal cancer? Onkologie. 2011;34:36-41.
382. Yu TK, Bhosale PR, Crane CH, et al. Patterns of locoregional recurrence after surgery and
radiotherapy or chemoradiation for rectal cancer. International journal of radiation oncology,
biology, physics. 2008;71:1175-1180.
383. Yukawa N, Yamamoto Y, Akaike M, et al. [Modified FOLFIRI (l-LV, 5-fluorouracil and
irinotecan) therapy for Japanese patients with metastatic colorectal cancer]. Gan to kagaku ryoho.
Cancer & chemotherapy. 2010;37:1291-1295.
384. Zaniboni A, Labianca R, Marsoni S, et al. GIVIO-SITAC 01: A randomized trial of adjuvant
5-fluorouracil and folinic acid administered to patients with colon carcinoma--long term results
and evaluation of the indicators of health-related quality of life. Gruppo Italiano Valutazione
Interventi in Oncologia. Studio Italiano Terapia Adiuvante Colon. Cancer. 1998;82:2135-2144.
385. Velenik V, Oblak I, Anderluh F. Long-term results from a randomized phase II trial of
neoadjuvant combined-modality therapy for locally advanced rectal cancer. Radiation oncology
(London, England). 2010;5:88.
386. von der Maase H, Magnusson K, Sveinsson T. Combined irradiation and three-drug
chemotherapy in inoperable colorectal carcinoma. Acta radiologica. Oncology. 1982;21:369-372.
387. Wagman R, Minsky BD, Cohen AM, Guillem JG, Paty PP. Sphincter preservation in rectal
cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up.
International journal of radiation oncology, biology, physics. 1998;42:51-57.
388. Wan DS. [Reevaluation of intraluminal fluorouracil chemotherapy as an adjuvant to radical
resection of colorectal cancer--results of a randomized trial]. Zhonghua zhong liu za zhi [Chinese
journal of oncology]. 1988;10:388-391.
389. Santini D, Vincenzi B, Addeo R, et al. Cetuximab rechallenge in metastatic colorectal cancer
patients: how to come away from acquired resistance? Annals of oncology : official journal of the
European Society for Medical Oncology / ESMO. 2012;23:2313-2318.
390. Santini D, Vincenzi B, Massacesi C, et al. S-adenosylmethionine (AdoMet) supplementation
for treatment of chemotherapy-induced liver injury. Anticancer research. 2003;23:5173-5179.
391. Santini D, Vincenzi B, Schiavon G, et al. Chronomodulated administration of oxaliplatin plus
capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II
study. Cancer chemotherapy and pharmacology. 2007;59:613-620.
392. Sanz-Altamira PM, Spence LD, Huberman MS, et al. Selective chemoembolization in the
management of hepatic metastases in refractory colorectal carcinoma: a phase II trial. Diseases of
the colon and rectum. 1997;40:770-775.
393. Saridaki Z, Androulakis N, Vardakis N, et al. A triplet combination with irinotecan (CPT-11),
oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus
cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial.
British journal of cancer. 2012;107:1932-1937.
394. Sasaki Y, Shimizu H, Naka W, Takeshita E, Nishikawa T. Evaluation of the clinical
usefulness of measuring urinary excretion of 5-S-cysteinyldopa in melanoma: ten years'
experience of 50 patients. Acta dermato-venereologica. 1997;77:379-381.
395. Sato A, Kurihara M, Horikoshi N, et al. Phase II study of raltitrexed (Tomudex) in
chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study
Group. Anti-cancer drugs. 1999;10:741-748.
396. Sato KT, Omary RA, Takehana C, et al. The role of tumor vascularity in predicting survival
after yttrium-90 radioembolization for liver metastases. Journal of vascular and interventional
radiology : JVIR. 2009;20:1564-1569.
397. Sato M, Watanabe Y, Ueda S, et al. Microwave coagulation therapy for hepatocellular
carcinoma. Gastroenterology. 1996;110:1507-1514.
398. Sato N, Sano M, Tabei T, et al. Combination docetaxel and trastuzumab treatment for patients
with HER-2-overexpressing metastatic breast cancer: a multicenter, phase-II study. Breast cancer
(Tokyo, Japan). 2006;13:166-171.
399. Sato T, Eschelman DJ, Gonsalves CF, et al. Immunoembolization of malignant liver tumors,
including uveal melanoma, using granulocyte-macrophage colony-stimulating factor. Journal of
clinical oncology : official journal of the American Society of Clinical Oncology.
2008;26:5436-5442.
400. Satoi S, Yamamoto H, Takai S, et al. Clinical impact of multidetector row computed
tomography on patients with pancreatic cancer. Pancreas. 2007;34:175-179.
401. Saunders MP, Hogg M, Carrington B, et al. Phase I dose-escalation trial of irinotecan with
continuous infusion 5-FU first line, in metastatic colorectal cancer. British journal of cancer.
2004;91:1447-1452.
402. Sautner T, Hofbauer F, Depisch D, Schiessel R, Jakesz R. Adjuvant intraperitoneal cisplatin
chemotherapy does not improve long-term survival after surgery for advanced gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
1994;12:970-974.
403. Savelli G, Lucignani G, Seregni E, et al. Feasibility of somatostatin receptor scintigraphy in
the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours. Nuclear
medicine communications. 2004;25:445-449.
404. Sawaguchi S, Kaneko M, Uchino J, et al. Treatment of advanced neuroblastoma with
emphasis on intensive induction chemotherapy. A report from the Study Group of Japan. Cancer.
1990;66:1879-1887.
405. Schaaf LJ, Hammond LA, Tipping SJ, et al. Phase 1 and pharmacokinetic study of
intravenous irinotecan in refractory solid tumor patients with hepatic dysfunction. Clinical cancer
research : an official journal of the American Association for Cancer Research.
2006;12:3782-3791.
406. Schafer HH, Vivaldi C, Holscher AH. [Local excision with transanal endoscopic
microsurgery (TEM) after endoscopic R1/R2-polypectomy of pT1 "low-risk" carcinomas of the
rectum]. Zeitschrift fur Gastroenterologie. 2006;44:647-650.
407. Scheer MG, Stollman TH, Vogel WV, Boerman OC, Oyen WJ, Ruers TJ. Increased metabolic
activity of indolent liver metastases after resection of a primary colorectal tumor. Journal of
nuclear medicine : official publication, Society of Nuclear Medicine. 2008;49:887-891.
408. Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I
trial of stereotactic body radiation therapy (SBRT) for liver metastases. International journal of
radiation oncology, biology, physics. 2005;62:1371-1378.
409. Scheibenbogen C, Schmittel A, Keilholz U, et al. Phase 2 trial of vaccination with tyrosinase
peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic
melanoma. Journal of immunotherapy (Hagerstown, Md. : 1997). 2000;23:275-281.
410. Scheidhauer K, Muller S, Smolarz K, Brautigam P, Briele B. [Tumor scintigraphy using
123I-labeled estradiol in breast cancer--receptor scintigraphy]. Nuklearmedizin. Nuclear medicine.
1991;30:84-99.
411. Scheithauer W, Schull B, Ulrich-Pur H, et al. Biweekly high-dose gemcitabine alone or in
combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a
randomized phase II trial. Annals of oncology : official journal of the European Society for
Medical Oncology / ESMO. 2003;14:97-104.
412. Schiavon G, Ruggiero A, Bekers DJ, et al. The effect of baseline morphology and its change
during treatment on the accuracy of Response Evaluation Criteria in Solid Tumours in assessment
of liver metastases. European journal of cancer (Oxford, England : 1990). 2014;50:972-980.
413. Schick F, Stern W, Forster J, Laniado M, Lutz O, Claussen CD. Magnetization transfer
contrast of hepatic lesions in breath-hold gradient-echo images of different T1 weighting. Journal
of magnetic resonance imaging : JMRI. 1997;7:280-285.
414. Schiepers C, Haustermans K, Geboes K, Filez L, Bormans G, Penninckx F. The effect of
preoperative radiation therapy on glucose utilization and cell kinetics in patients with primary
rectal carcinoma. Cancer. 1999;85:803-811.
415. Schiepers C, Penninckx F, De Vadder N, et al. Contribution of PET in the diagnosis of
recurrent colorectal cancer: comparison with conventional imaging. European journal of surgical
oncology : the journal of the European Society of Surgical Oncology and the British Association
of Surgical Oncology. 1995;21:517-522.
416. Schilling H, Bornfeld N, Talies S, et al. [Endoresection of large uveal melanomas after
pretreatment by single-dose stereotactic convergence irradiation with the leksell gamma
knife--first
experience
on
46
cases].
Klinische
Monatsblatter
fur
Augenheilkunde.
2006;223:513-520.
417. Schimanski CC, Mohler M, Schon M, et al. LICC: L-BLP25 in patients with colorectal
carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled,
multicenter, multinational, double-blinded phase II trial. BMC cancer. 2012;12:144.
418. Schindler CG, Armbrust T, Gunawan B, Langer C, Fuzesi L, Ramadori G. Gastrointestinal
stromal tumor (GIST) -- single center experience of prolonged treatment with imatinib. Zeitschrift
fur Gastroenterologie. 2005;43:267-273.
419. Schirrmeister H, Kuhn T, Guhlmann A, et al. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in
the preoperative staging of breast cancer: comparison with the standard staging procedures.
European journal of nuclear medicine. 2001;28:351-358.
420. Schlag P, Manasterski M, Gerneth T, et al. Active specific immunotherapy with
Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases
in colorectal cancer. First evaluation of clinical response of a phase II-trial. Cancer immunology,
immunotherapy : CII. 1992;35:325-330.
421. Schlottmann K, Klebl F, Zorger N, Feuerbach S, Scholmerich J. Contrast-enhanced
ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode.
Zeitschrift fur Gastroenterologie. 2004;42:303-310.
422. Schmid P, Akrivakis K, Flath B, et al. Phase II trial of gemcitabine as prolonged infusion in
metastatic breast cancer. Anti-cancer drugs. 1999;10:625-631.
423. Schmid P, Heilmann V, Schulz CO, et al. Gemcitabine as prolonged infusion and vinorelbine
in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study. Journal of
cancer research and clinical oncology. 2005;131:568-574.
424. Schmidt GP, Baur-Melnyk A, Herzog P, et al. High-resolution whole-body magnetic
resonance image tumor staging with the use of parallel imaging versus dual-modality positron
emission tomography-computed tomography: experience on a 32-channel system. Investigative
radiology. 2005;40:743-753.
425. Schmidt JD, Gibbons RP, Johnson DE, Prout GR, Scott WW, Murphy GP. Chemotherapy of
advanced prostatic cancer. Evaluation of response parameters. Urology. 1976;7:602-610.
426. Schmidt T, Koch M, Antolovic D, et al. Influence of two different resection techniques
(conventional liver resection versus anterior approach) of liver metastases from colorectal cancer
on hematogenous tumor cell dissemination - prospective randomized multicenter trial. BMC
surgery. 2008;8:6.
427. Schmitz R, Krakamp B, Mennigen R, Barkun J, Klauke H. Value of in vivo tissue testing in
predicting the clinical response to regional perfusion chemotherapy in colorectal cancer patients
with
liver
metastases.
Strahlentherapie
und
Onkologie
:
Organ
der
Deutschen
Rontgengesellschaft ... [et al]. 1989;165:546-547.
428. Schmitz SA, Haberle JH, Balzer T, Shamsi K, Boese-Landgraf J, Wolf KJ. Detection of focal
liver lesions: CT of the hepatobiliary system with gadoxetic acid disodium, or Gd-EOB-DTPA.
Radiology. 1997;202:399-405.
429. Schmitz T, Appelman K, Kudejova P, et al. Determination of boron concentration in blood
and tissue samples from patients with liver metastases of colorectal carcinoma using Prompt
Gamma Ray Activation Analysis (PGAA). Applied radiation and isotopes : including data,
instrumentation and methods for use in agriculture, industry and medicine. 2011;69:936-941.
430. Schmitz T, Blaickner M, Schutz C, et al. Dose calculation in biological samples in a mixed
neutron-gamma field at the TRIGA reactor of the University of Mainz. Acta oncologica
(Stockholm, Sweden). 2010;49:1165-1169.
431. Schnater JM, Aronson DC, Plaschkes J, et al. Surgical view of the treatment of patients with
hepatoblastoma: results from the first prospective trial of the International Society of Pediatric
Oncology Liver Tumor Study Group. Cancer. 2002;94:1111-1120.
432. Schneebaum S, Papo J, Graif M, Baratz M, Baron J, Skornik Y. Radioimmunoguided surgery
benefits for recurrent colorectal cancer. Annals of surgical oncology. 1997;4:371-376.
433. Schneebaum S, Troitsa A, Avital S, et al. Identification of lymph node metastases in recurrent
colorectal cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans
les recherches sur le cancer. 2000;157:281-292.
434. Schneider BJ, El-Rayes B, Muler JH, et al. Phase II trial of carboplatin, gemcitabine, and
capecitabine in patients with carcinoma of unknown primary site. Cancer. 2007;110:770-775.
435. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest
radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology.
1998;114:7-14.